Hologic Announces Financial Results for First Quarter of Fiscal 2018

Go back to Hologic Announces Financial Results for First Quarter of Fiscal 2018

Hologic (HOLX) PT Lowered to $48 at Canaccord Genuity Following 1Q Results

February 12, 2018 7:54 AM EST

Canaccord Genuity lowered its price target on Hologic (NASDAQ: HOLX) to $48.00 (from $50.00) while maintaining a Buy rating following the company's 1Q results. Revenues of ~$791M beat the Street's $786M, and adjusted EPS of $0.55 beat the Street's $0.50.

HOLX reiterated its prior FY'18... More